NeuroOne Medical Technologies
(NASDAQ) NMTC
NeuroOne Medical Technologies Financials at a Glance
Market Cap
$30.00M
Revenue (TTM)
$9.72M
Net Income (TTM)
-$6.64M
EPS (TTM)
-$0.80
P/E Ratio
-4.37
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Price
$3.43
Volume
20,858
Open
$3.54
Price
$3.43
Volume
20,858
Open
$3.54
Previous Close
$3.44
Daily Range
$3.37 - $3.55
52-Week Range
$3.27 - $6.96
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Price
$3.43
Volume
20,858
Open
$3.54
Previous Close
$3.44
Daily Range
$3.37 - $3.55
52-Week Range
$3.27 - $6.96
Estimated Earnings Date
Aug 13, 2026
NMTC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout NeuroOne Medical Technologies
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
18
CEO
David A. Rosa, MBA
Website
nmtc1.comHeadquarters
Eden Prairie, MN 55344, US
NMTC Financials
Key Financial Metrics (TTM)
Gross Margin
55%
Operating Margin
-73%
Net Income Margin
-68%
Return on Equity
-204%
Return on Capital
-1%
Return on Assets
-84%
Earnings Yield
-22.88%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$30.00M
Shares Outstanding
8.62M
Volume
20.86K
Avg. Volume
37.32K
Financials (TTM)
Gross Profit
$8.14M
Operating Income
-$4.23M
EBITDA
-$3.01M
Operating Cash Flow
-$2.84M
Capital Expenditure
-$81.74K
Free Cash Flow
-$2.92M
Cash & ST Invst.
$6.57M
Total Debt
$266.81K
NeuroOne Medical Technologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.39M
+72.5%
Gross Profit
$1.29M
+66.9%
Gross Margin
53.81%
N/A
Market Cap
$30.00M
N/A
Market Cap/Employee
$1.76M
N/A
Employees
17
N/A
Net Income
-$2.09M
+8.1%
EBITDA
-$2.04M
+7.4%
Quarterly Fundamentals
Net Cash
$2.60M
+157.4%
Accounts Receivable
$2.43M
+661.2%
Inventory
$1.87M
+1.7%
Long Term Debt
$92.36K
-55.4%
Short Term Debt
$114.61K
+9.7%
Return on Assets
-84.47%
N/A
Return on Invested Capital
-1.14%
N/A
Free Cash Flow
-$1.37M
-2205.0%
Operating Cash Flow
-$1.33M
-2266.6%